Facts & Figures

As of January 5, 2015

  1. NRG (Nuclear Research and consultancy Group) is the Netherlands’ primary nuclear service provider.

  2. In the areas of technology, the safety system and the organisation, NRG imposes the most stringent requirements on itself. At NRG, the principle is always, ‘we do it safely or not at all’.

  3. Through its extensive network of international partners, NRG is a global player.

  4. NRG operates in the following sectors: energy, health, industry, government and technology.

  5. NRG’s products and internationally renowned expertise are widely used by both government and industry.

  6. NRG manages the HFR (High Flux Reactor) at Petten.

  7. NRG is Europe’s largest producer of medical isotopes.

  8. NRG’s world market share is over 30% in the production of medical isotopes and is thus the second supplier in the world.

  9. Every day, radiopharmaceutical products and medical isotopes help over 24,000 patients.

  10. The reactor is manned 24 hours.

  11. A reactor team comprises seven people. There are five teams in total.

  12. NRG has 434 permanent employees.

  13. NRG’s employees comprise 346 men and 88 women.

  14. There are 14 different nationalities at NRG.

  15. NRG believes that nuclear technology is essential for a sustainable society.

  16. NRG’s radiopharmaceutical products and medical isotopes for diagnosis, therapy and pain relief are used all over the world.

  17. NRG is continuously searching for new applications and new products. Another consideration is the sustained focus on the safety of nuclear power stations and attractive alternatives for nuclear waste management, including recycling technologies. NRG also conducts applied research into improving the sustainability of nuclear energy.

  18. NRG is working on building the PALLAS reactor, the replacement for the present HFR. PALLAS will be equipped so that it operates more efficiently and effectively and thus meets the growing demand for medical isotopes and nuclear knowledge.

  19. NRG has sites in Petten and Arnhem.

  20. Within around 10 years, the PALLAS reactor is due to replace the present High Flux Reactor (HFR) in Petten, which has now been in operation for over fifty years and is approaching the end of its economic life span.